病例分享:渴络欣胶囊治疗1型糖尿病患者慢性肾脏病1例

2018-10-31 施萍(成都市第一人民医院肾内科 ) 中华医学信息导报

16年前经相关检查明确诊断为“1型糖尿病”,1年前发现血压升高,最高血压160/110 mmHg,未重视,未随访血压。1年前因怀孕发现血肌酐286 μmol/L,终止妊娠后行肾活检,明确诊断为“慢性肾功能不全、CKD Ⅳ期,1型糖尿病、糖尿病肾病、肾性贫血、肾性高血压”。

患者资料

患者,女,30岁,因“慢性肾功能衰竭,1型糖尿病,肺部感染”于2018年5月16日收于我科。

16年前经相关检查明确诊断为“1型糖尿病”,1年前发现血压升高,最高血压160/110 mmHg,未重视,未随访血压。1年前因怀孕发现血肌酐286 μmol/L,终止妊娠后行肾活检,明确诊断为“慢性肾功能不全、CKD Ⅳ期,1型糖尿病、糖尿病肾病、肾性贫血、肾性高血压”。患者自诉无家族史,否认冠心病史、传染病史、过敏史;有“心动过速”病史16年,甲状腺功能异常史;16年前行“阑尾切除术”史(具体不详);3年前因糖尿病眼底病变,左眼眼底出血行左眼玻璃体切除,现左眼视力较弱;1年前于我院妇科行引产术;长期接受降压、纠正贫血、控制血糖等对症治疗控制病情,间断随访血糖血压稳定,但血肌酐未随访。

此次入院后实验室检查结果:



诊断为“慢性肾脏病CKD V期,1型糖尿病,糖尿病肾病,肾性贫血,肾性高血压,糖尿病视网膜病变。消渴肾病,气阴两虚。”

治疗方案

糖尿病肾病是一个一体化的治疗,而不仅仅是针对血糖的控制,眼底、肾脏、血管等靶器官的治疗同样重要。本病例中,患者自认血压、血糖控制良好,但忽略了尿蛋白及肾功能的随访;结合患者依从性较差,导致患者肾功能进行性恶化。

此外,患者有大量尿蛋白,同时血肌肝升高并进入尿毒症阶段,开始血液透析治疗。但仍伴有身体疲乏无力,心烦不耐热,大便干燥等临床症状,导致患者的透析耐受性和依从性差,影响透析的充分性。

针对以上2个主要问题,对该患者予以定期透析治疗,3次/周,辅以渴络欣胶囊以改善症状;同时针对其他病情予以对症一体化治疗,具体方案见表1。

表1 治疗方案



3个月后复诊,检查肌酐815 μmol/L,肾小球滤过率12.9 ml/min,尿糖(-),尿蛋白(2+),空腹葡萄糖7.8 mmol/L见表2。

表2 治疗效果



谈论思考,主要三点

1.患者糖尿病、糖尿病肾病并进入终末期肾病,予以维持性血液透析,但患者的临床症状影响到透析的依从性(减少透析时间),因此选择用药方案时在透析基础上加用渴络欣胶囊以改善症状。同时使用胰岛素、纠正贫血、控制血压、及血液透析清除毒素、对症等综合治疗下,患者的临床表现得到控制,用药后临床治疗效果较好,患者依从性也更好。

2.治疗前,患者存在疲乏、五心烦热,大便干燥等症状;透析配合使用益气养阴、活血化瘀功效的渴络欣胶囊后,患者自觉症状有所缓解,精神好转,大便也有所改善,总体获益明显。而对于后续的治疗,则需要加强患者教育,严格控制血糖、血压和蛋白摄入。提高患者的依从性。

3.该病案也提示,糖尿病肾病早期治疗中使用渴络欣胶囊,对患者的蛋白尿的减少以及肾功的稳定,延缓病情,改善临床症状有积极作用。糖尿病患者也应积极监控病情,及早到肾内科监测蛋白尿及肾功能,并进行相关的干预性治疗,对肾脏的长期预后有所帮助。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1968269, encodeId=ac671968269ea, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=675, encryptionId=a4b96e542, topicName=1型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Dec 28 09:16:00 CST 2018, time=2018-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474633, encodeId=a98614e463372, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Nov 01 16:16:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616164, encodeId=0f71161616493, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Thu Nov 01 16:16:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041993, encodeId=dd861041993f3, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Oct 31 04:16:00 CST 2018, time=2018-10-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1968269, encodeId=ac671968269ea, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=675, encryptionId=a4b96e542, topicName=1型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Dec 28 09:16:00 CST 2018, time=2018-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474633, encodeId=a98614e463372, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Nov 01 16:16:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616164, encodeId=0f71161616493, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Thu Nov 01 16:16:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041993, encodeId=dd861041993f3, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Oct 31 04:16:00 CST 2018, time=2018-10-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1968269, encodeId=ac671968269ea, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=675, encryptionId=a4b96e542, topicName=1型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Dec 28 09:16:00 CST 2018, time=2018-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474633, encodeId=a98614e463372, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Nov 01 16:16:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616164, encodeId=0f71161616493, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Thu Nov 01 16:16:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041993, encodeId=dd861041993f3, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Oct 31 04:16:00 CST 2018, time=2018-10-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1968269, encodeId=ac671968269ea, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=675, encryptionId=a4b96e542, topicName=1型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Dec 28 09:16:00 CST 2018, time=2018-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474633, encodeId=a98614e463372, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Nov 01 16:16:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616164, encodeId=0f71161616493, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Thu Nov 01 16:16:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041993, encodeId=dd861041993f3, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Oct 31 04:16:00 CST 2018, time=2018-10-31, status=1, ipAttribution=)]
    2018-10-31 misszhang

    谢谢MedSci提供最新的资讯

    0